Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT04992546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Intra-patient, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis
Study identification
- NCT ID
- NCT04992546
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Principia Biopharma, a Sanofi Company
- Industry
- Enrollment
- 39 participants
Conditions and interventions
Conditions
Interventions
- PRN473 (SAR444727) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 12, 2021
- Primary completion
- Dec 27, 2022
- Completion
- Dec 27, 2022
- Last update posted
- Sep 9, 2025
2021 – 2022
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative Neuroscience Research-Site Number:8400004 | Long Beach | California | 90806 | — |
| California Allergy & Asthma Medical Group-Site Number:8400008 | Los Angeles | California | 90025 | — |
| Florida International Research Center-Site Number:8400017 | Miami | Florida | 33173 | — |
| Lenus Research & Medical Group-Site Number:8400006 | Sweetwater | Florida | 33172 | — |
| Clinical Research Trials of Florida, Inc-Site Number:8400013 | Tampa | Florida | 33607 | — |
| Remington Davis Inc-Site Number:8400012 | Columbus | Ohio | 43215 | — |
| J&S Studies-Site Number:8400015 | Bryan | Texas | 77802 | — |
| Center for Clinical Studies, LTD. LLP-Site Number:8400014 | Houston | Texas | 77004 | — |
| Progressive Clinical Research-Site Number:8400002 | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04992546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04992546 live on ClinicalTrials.gov.